INTRAVASCULAR IMAGING/OPTICAL COHERENCE TOMOGRAPHY: FDA-approved device sees inside occluded arteries causing PAD

Jan. 1, 2013
Avinger has received FDA clearance for an OCT system that lets surgeons see inside an artery in real time.

Avinger (Redwood City, CA) has received FDA clearance for an optical coherence tomography (OCT) system that lets surgeons see inside an artery in real time. Previously, surgeons had to rely on x-ray imaging and tactile feedback to guide catheters through complicated blockages.

The approval followed a global clinical trial during which the Ocelot catheter demonstrated 97% success in crossing chronic total occlusions (CTO) with 98% freedom from major adverse events. Ocelot targets periphery artery disease (PAD), which results when plaque in the arteries blocks blood flow to the legs and feet, and promises to help patients avoid bypass surgeries and amputations.

Sponsored Recommendations

March 31, 2025
Enhance your remote sensing capabilities with Chroma's precision-engineered optical filters, designed for applications such as environmental monitoring, geospatial mapping, and...
March 31, 2025
Designed for compatibility with a wide range of systems, Chroma's UV filters are engineered to feature high transmission, superior out-of-band blocking, steep edge transitions...
March 31, 2025
Discover strategies to balance component performance and system design, reducing development time and costs while maximizing efficiency.
March 31, 2025
Filter accessories including cubes, sliders, and rings, designed to enhance the performance and versatility of optical systems. These components ensure precise alignment and stability...

Voice your opinion!

To join the conversation, and become an exclusive member of Laser Focus World, create an account today!